Japan Beverage Giant Suntory Holdings Buys Japan $34 Billion Pharmaceutical Giant Daiichi Sankyo Healthcare Unit Daiichi Sankyo Healthcare for $1.6 Billion (JPY 246.5 Billion) in All-Cash Deal, Daiichi Sankyo Founded in 2005 with Merger of Sankyo Company (Founded 1899) & Daiichi Pharmaceutical Company (Founded 1915)
19th April 2026 | Hong Kong
Japan beverage giant Suntory Holdings has announced to buy Japan pharmaceutical giant Daiichi Sankyo ($34 billion market value) healthcare unit Daiichi Sankyo Healthcare for $1.6 billion (JPY 246.5 billion) in all-cash deal. Daiichi Sankyo was founded in 2005 with the merger of Sankyo Company (Founded 1899) & Daiichi Pharmaceutical Company (Founded 1915). Daiichi Sankyo – Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. Suntory Holdings – As a global leader in the beverage industry, Suntory Group aims to inspire the brilliance of life, by creating rich experiences for people, in harmony with nature. Sustained by the gifts of nature and water, the Group offers a uniquely diverse portfolio of products, from award-winning Japanese whiskies Yamazaki and Hibiki, iconic American whiskies Jim Beam and Maker’s Mark, canned ready-to-drink -196 (minus one-nine-six), The Premium Malt’s beer, Japanese wine Tomi, and the world-famous Château Lagrange. Founded as a family-owned business in 1899 in Osaka, Japan. Suntory Group operates throughout the Americas, Europe, Africa, Asia and Oceania, with an annual revenue (excluding excise taxes) of $20.5 billion in 2025. Its 41,628 employees worldwide draw upon the unique blend of Japanese artisanship and global tastes to explore new product categories and markets.
“ Japan Beverage Giant Suntory Holdings Buys Japan $34 Billion Pharmaceutical Giant Daiichi Sankyo Healthcare Unit Daiichi Sankyo Healthcare for $1.6 Billion (JPY 246.5 Billion) in All-Cash Deal, Daiichi Sankyo Founded in 2005 with Merger of Sankyo Company (Founded 1899) & Daiichi Pharmaceutical Company (Founded 1915) “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
Japan Beverage Giant Suntory Holdings Buys Japan $34 Billion Pharmaceutical Giant Daiichi Sankyo Healthcare Unit Daiichi Sankyo Healthcare for $1.6 Billion (JPY 246.5 Billion) in All-Cash Deal, Daiichi Sankyo Founded in 2005 with Merger of Sankyo Company (Founded 1899) & Daiichi Pharmaceutical Company (Founded 1915)
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
